Literature DB >> 27692879

Drug Repurposing: New Treatments for Zika Virus Infection?

Feixiong Cheng1, James L Murray2, Donald H Rubin3.   

Abstract

To date, no antiviral agents have been approved for treating Zika virus (ZIKV) infection. Two recent drug-repurposing studies published in Cell Host & Microbe and Nature Medicine demonstrated that screening FDA-approved drugs for antiviral activity is a promising strategy for identifying therapeutics with novel activity against ZIKV infection.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Zika virus; antiviral; drug repurposing; mechanism-of-action

Mesh：

Substances：

Year:  2016        PMID： 27692879     DOI： 10.1016/j.molmed.2016.09.006

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN： 1471-4914            Impact factor:   11.951


  26 in total

1.  Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2.

Authors:  Yadi Zhou; Yuan Hou; Jiayu Shen; Yin Huang; William Martin; Feixiong Cheng
Journal:  Cell Discov       Date:  2020-03-16       Impact factor: 10.849

Review 2.  Zika clinical updates: implications for pediatrics.

Authors:  Kristina Adachi; Karin Nielsen-Saines
Journal:  Curr Opin Pediatr       Date:  2018-02       Impact factor: 2.856

Review 3.  Zika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus Network.

Authors:  Matthew T Aliota; Leda Bassit; Shelton S Bradrick; Bryan Cox; Mariano A Garcia-Blanco; Christina Gavegnano; Thomas C Friedrich; Thaddeus G Golos; Diane E Griffin; Andrew D Haddow; Esper G Kallas; Uriel Kitron; Marc Lecuit; Diogo M Magnani; Caroline Marrs; Natalia Mercer; Edward McSweegan; Lisa F P Ng; David H O'Connor; Jorge E Osorio; Guilherme S Ribeiro; Michael Ricciardi; Shannan L Rossi; George Saade; Raymond F Schinazi; Geraldine O Schott-Lerner; Chao Shan; Pei-Yong Shi; David I Watkins; Nikos Vasilakis; Scott C Weaver
Journal:  Antiviral Res       Date:  2017-06-06       Impact factor: 5.970

4.  SperoPredictor: An Integrated Machine Learning and Molecular Docking-Based Drug Repurposing Framework With Use Case of COVID-19.

Authors:  Faheem Ahmed; Jae Wook Lee; Anupama Samantasinghar; Young Su Kim; Kyung Hwan Kim; In Suk Kang; Fida Hussain Memon; Jong Hwan Lim; Kyung Hyun Choi
Journal:  Front Public Health       Date:  2022-06-16

Review 5.  Advances in Developing Therapies to Combat Zika Virus: Current Knowledge and Future Perspectives.

Authors:  Ashok Munjal; Rekha Khandia; Kuldeep Dhama; Swati Sachan; Kumaragurubaran Karthik; Ruchi Tiwari; Yashpal S Malik; Deepak Kumar; Raj K Singh; Hafiz M N Iqbal; Sunil K Joshi
Journal:  Front Microbiol       Date:  2017-08-03       Impact factor: 5.640

6.  Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: inhibiting viral replication and decreasing viral entry.

Authors:  Shu Yang; Miao Xu; Emily M Lee; Xiangguo Qiu; Alexey V Terskikh; Hengli Tang; Hongjun Song; Wei Zheng; Kirill Gorshkov; Sergey A Shiryaev; Shihua He; Wei Sun; Yu-Shan Cheng; Xin Hu; Anil Mathew Tharappel; Billy Lu; Antonella Pinto; Chen Farhy; Chun-Teng Huang; Zirui Zhang; Wenjun Zhu; Yuying Wu; Yi Zhou; Guang Song; Heng Zhu; Khalida Shamim; Carles Martínez-Romero; Adolfo García-Sastre; Richard A Preston; Dushyantha T Jayaweera; Ruili Huang; Wenwei Huang; Menghang Xia; Anton Simeonov; Guoli Ming
Journal:  Cell Discov       Date:  2018-06-05       Impact factor: 10.849

7.  Longitudinal [18F]FB-IL-2 PET Imaging to Assess the Immunopathogenicity of O'nyong-nyong Virus Infection.

Authors:  Yi-Hao Chan; Teck-Hui Teo; Anthony Torres-Ruesta; Siddesh V Hartimath; Rhonda Sin-Ling Chee; Shivashankar Khanapur; Fui Fong Yong; Boominathan Ramasamy; Peter Cheng; Ravisankar Rajarethinam; Edward G Robins; Julian L Goggi; Fok-Moon Lum; Guillaume Carissimo; Laurent Rénia; Lisa F P Ng
Journal:  Front Immunol       Date:  2020-05-12       Impact factor: 7.561

8.  Potential drugs against COVID-19 revealed by gene expression profile, molecular docking and molecular dynamic simulation.

Authors:  Claudia Cava; Gloria Bertoli; Isabella Castiglioni
Journal:  Future Virol       Date:  2021-07-20       Impact factor: 1.831

9.  A Network Medicine Approach to Investigation and Population-based Validation of Disease Manifestations and Drug Repurposing for COVID-19.

Authors:  Yadi Zhou; Yuan Hou; Jiayu Shen; Asha Kallianpur; Joe Zein; Daniel A Culver; Samar Farha; Suzy Comhair; Claudio Fiocchi; Michaela U Gack; Reena Mehra; Thaddeus Stappenbeck; Timothy Chan; Charis Eng; Jae U Jung; Lara Jehi; Serpil Erzurum; Feixiong Cheng
Journal:  ChemRxiv       Date:  2020-07-02

10.  Mapping the intellectual structure of the coronavirus field (2000-2020): a co-word analysis.

Authors:  Aliakbar Pourhatami; Mohammad Kaviyani-Charati; Bahareh Kargar; Hamed Baziyad; Maryam Kargar; Carlos Olmeda-Gómez
Journal:  Scientometrics       Date:  2021-06-15       Impact factor: 3.238
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.